XYL Xylem Inc. | US98419M1009
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 9.614.831.400 | 9.251.778.380 | 3.92% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 6,10 | 5,54 | 10.14% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 22 | 22 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |